Accurate quantification of impurities in pure peptide material - angiotensin I: Comparison of calibration requirements and method performance characteristics of liquid chromatography coupled to hybrid tandem mass spectrometry and linear ion trap high-resolution mass spectrometry.

作者: N. Stoppacher , R. D. Josephs , A. Daireaux , T. Choteau , S. Westwood

DOI: 10.1002/RCM.7261

关键词:

摘要: Rationale The prohormone angiotensin I (ANG I) [amino acid sequence: DRVYIHPFHL] and other structurally related peptide hormones play an essential role in the regulation of water electrolyte balance human body as well blood pressure. ANG is a biomarker for hypertension diabetes. Therefore, well-characterized pure reference materials comparable SI-traceable analytical characterization methods are required to establish measurement systems (RMS) laboratory medicine. Methods Two based on liquid chromatography/mass spectrometry (LC/MS) with electrospray ionization have been developed validated in-house. Both high-resolution MS (hrMS) hybrid-tandem MS/MS were used identification quantification major impurities I. The quantified by use external calibrations original impurity standards. Mass fraction values corresponding expanded uncertainties calculated. Results Five degradation products detected 'pure' material. peptides (2-10) [RVYIHPFHL], II [DRVYIHPF] three isomers [DRVYLHPFHL, DRVYIHPFHI DRVYLHPFHI] identified mass calculated that range from 0.66 4.86 mg/g. Conclusions The material obtained both LC/hrMS LC/MS/MS excellent agreement. This study emphasizes importance spectrometric techniques application approaches value uncertainty assignment substance peptides. Copyright © 2015 John Wiley & Sons, Ltd.

参考文章(15)
N. Stoppacher, R. D. Josephs, A. Daireaux, T. Choteau, S. W. Westwood, R. I. Wielgosz, Impurity identification and determination for the peptide hormone angiotensin I by liquid chromatography–high-resolution tandem mass spectrometry and the metrological impact on value assignments by amino acid analysis Analytical and Bioanalytical Chemistry. ,vol. 405, pp. 8039- 8051 ,(2013) , 10.1007/S00216-013-6953-7
Q. Li, J. Zhang, M. Pfaffendorf, P.A. Zwieten, Comparative effects of angiotensin II and its degradation products angiotensin III and angiotensin IV in rat aorta British Journal of Pharmacology. ,vol. 116, pp. 2963- 2970 ,(1995) , 10.1111/J.1476-5381.1995.TB15951.X
Ralf Dieter Josephs, Adeline Daireaux, Steven Westwood, Robert Ian Wielgosz, Simultaneous determination of various cardiac glycosides by liquid chromatography–hybrid mass spectrometry for the purity assessment of the therapeutic monitored drug digoxin Journal of Chromatography A. ,vol. 1217, pp. 4535- 4543 ,(2010) , 10.1016/J.CHROMA.2010.04.060
Ralf Dieter Josephs, Robert Koeber, Thomas Peter Josef Linsinger, Alexander Bernreuther, Franz Ulberth, Heinz Schimmel, Production of certified reference materials for mycotoxins: IRMM's view on the assessment of uncertainties Analytical and Bioanalytical Chemistry. ,vol. 378, pp. 1190- 1197 ,(2004) , 10.1007/S00216-003-2458-0
John W. Wright, Shigehiko Mizutani, Joseph W. Harding, Focus on Brain Angiotensin III and Aminopeptidase A in the Control of Hypertension International Journal of Hypertension. ,vol. 2012, pp. 124758- 124758 ,(2012) , 10.1155/2012/124758
Steven Westwood, Tiphaine Choteau, Adeline Daireaux, Ralf Dieter Josephs, Robert Ian Wielgosz, Mass balance method for the SI value assignment of the purity of organic compounds. Analytical Chemistry. ,vol. 85, pp. 3118- 3126 ,(2013) , 10.1021/AC303329K
Huihui Li, Gu Yuan, Electrospray ionization mass spectral characteristics and fragmentation mechanisms of Angiotensin II and its analogues International Journal of Mass Spectrometry. ,vol. 252, pp. 54- 60 ,(2006) , 10.1016/J.IJMS.2006.02.016
Lijie Cui, Kasem Nithipatikom, William B. Campbell, Simultaneous analysis of angiotensin peptides by LC-MS and LC-MS/MS: metabolism by bovine adrenal endothelial cells. Analytical Biochemistry. ,vol. 369, pp. 27- 33 ,(2007) , 10.1016/J.AB.2007.06.045
Ana Simoes-e-Silva, The renin–angiotensin system and diabetes: An update Vascular Health and Risk Management. ,vol. 4, pp. 787- 803 ,(2008) , 10.2147/VHRM.S1905